The p38 MAPK inhibitor SB202190, the SAPK/JNK MAPK inhibitor JNK II, or both were added to Myd88−/− or WT macrophages at 120 minutes post-infection, the time of peak MyD88-independent, T4SS-dependent MAPK activation. The gene discussed is MAPK9; the disease is infection.